9 December 2020 ID93+GLA-SE candidate TB vaccine appears safe and immunogenic in treated TB patients
9 Dec 2020 - 20:30
The results from the ID93+GLA-SE TB vaccine clinical trial have just been published in the Lancet Respiratory Medicine journal. The candidate vaccine displayed an acceptable safety profile and provides encouraging evidence of vaccine-induced immune responses when given to cured TB patients at the end of treatment.
View abstract online. Click here.
Download media statement. Click here.
Worcester Site Office:
SATVI Project Office, University of Cape Town, Brewelskloof Hospital, Haarlem Street, WORCESTER, 6850.
Tel: +27 23 346 5400
Fax: +27 23 346 5406
Email: Field Site Manager
Google maps: Click here GPS: -33.620455, 19.458576
Map to Worcester Field Office